FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced plans to broaden the activities of its joint venture with the Shijiazhuang Pharmaceutical Group Co., Ltd (“SPG”) and to expand the potential product line to be developed and marketed by the joint venture.
